Skip to content
Journal

Journal of Advances in Medical and Pharmaceutical Sciences

Published by SCIENCEDOMAIN international · ISSN (electronic) 2394-1111

Search within this journal

889

Articles indexed

63

2026 articles

889

Open access

3,568

Citations (indexed)

Publications by year

Articles (889)

Self-Medication with Analgesics among Community Pharmacy Clients in Yenagoa, Nigeria: Patterns, Demographic Correlates and Public Health Implications

Timi Fiekumo Buseri, Ibegi, Ibegi Saviour, Success Tamunoibi Gwembe, Keme Kelvin Yenagoa & Buseri, Oyintokoni Beauty · Journal of Advances in Medical and Pharmaceutical Sciences · 2026

Background: Self-medication is a global public health practice conventionally dominated by analgesics, antipyretics and antimicrobials, yet the demographic structure of this behaviour and its association with information sources remain poorly characterised in Nigerian community p...

Open access Research Article 10.9734/jamps/2026/v28i9892

Reducing False Positives and False Negatives in Artificial Intelligence-assisted Imaging Screening: A Critical Review of Accuracy, Error Mechanisms and Clinical Translation

Musa Shamaki Ibrahim, Enock Kumi Ackaah, Charity Benewa Acheampong, Bukola E Shasere, Susana Owusu-Ansah, Godliver Awonlie Alangyam & Emmanuel Arhin · Journal of Advances in Medical and Pharmaceutical Sciences · 2026

Imaging-based screening programmes are constrained by two opposing failures: false-positive results that generate unnecessary recall, anxiety, further imaging and biopsy, and false-negative results that permit disease to progress undetected until the next screening round or until...

Open access Research Article 10.9734/jamps/2026/v28i9891

Osteogenesis Imperfecta from Historical Nosology to Gene-directed Therapy: A Critical Narrative Review of Mechanism, Evidence and Translational Uncertainty

Stefan Bittmann, Elisabeth Luchter & Elena Moschüring-Alieva · Journal of Advances in Medical and Pharmaceutical Sciences · 2026

Osteogenesis imperfecta is the prototypical heritable disorder of bone fragility, and the last three decades have transformed it from a clinically defined syndrome into a molecularly stratified group of conditions involving more than twenty genes. That transformation has not been...

Open access Research Article 10.9734/jamps/2026/v28i9890

Glucagon in Endocrine and Metabolic Practice: A Critical Narrative Review of Stimulation Testing, Diagnostic Cut-points and Therapeutic Use in Children, Adolescents and Adults

Ashraf T. Soliman, Fawzia Alyafei, Nada Alaaraj, Noor Hamed, Shayma Ahmed & Nada Soliman · Journal of Advances in Medical and Pharmaceutical Sciences · 2026

Glucagon occupies an unusual position in clinical endocrinology. The same 29-amino-acid peptide serves as a provocative agent for pituitary function testing, as an emergency treatment for severe hypoglycaemia, as a continuous infusion in hyperinsulinaemic states of infancy, and,...

Open access Research Article 10.9734/jamps/2026/v28i9889

Development and Validation of New Analytical Method for Determination of Particle Size Distribution in Alogliptin Benzoate Drug Substance Using Laser-based Particle Size Analyzer

Jitendra Kumar Dubey, Jitendra Koundinya, Babul Nishad, Praveen Choubay, Nirav Parekh, Mehul Gujrati, Pankaj T. Shah & Frenil Vaidya · Journal of Advances in Medical and Pharmaceutical Sciences · 2026

Particle size distribution (PSD) characterisation is important for pharmaceutical drug-substance quality because particle size can influence formulation-related performance. This study developed and validated a wet-dispersion laser-diffraction method for determining the PSD of Al...

Open access Research Article 10.9734/jamps/2026/v28i9887

Governance and Performance Dashboards for Managing Healthcare Analytics and Artificial Intelligence Implementation Projects in Hospital Systems: A Critical Review

Ododoade Idowu Adewuyi & Moshood Khairah Olayinka · Journal of Advances in Medical and Pharmaceutical Sciences · 2026

Hospital systems are adopting predictive analytics and artificial intelligence at a pace that has outstripped the development of the organisational machinery required to supervise them. Two bodies of scholarship have grown in parallel to address this problem. The first proposes g...

Open access Research Article 10.9734/jamps/2026/v28i9888

Predictive ADMET Assessment and Molecular Docking Analysis of Fisetin for Its Immunomodulatory Potential

Rakesh Tirkey · Journal of Advances in Medical and Pharmaceutical Sciences · 2026

Background: Immune-mediated diseases impose substantial clinical and socioeconomic burdens, while prolonged use of conventional immunosuppressive agents may be associated with serious adverse effects. Fisetin, a naturally occurring flavonoid, has demonstrated anti-inflammatory an...

Open access Research Article 10.9734/jamps/2026/v28i9886

Integrating Clinical, Operational, and Financial Data to Improve Project Outcomes in Digital Health Programs: A Critical Review

Bashiru Ibrahim & Jane Sharon Akinyemi · Journal of Advances in Medical and Pharmaceutical Sciences · 2026

Digital health programmes are commonly monitored through separate clinical, operational and financial reporting systems. This fragmentation obscures whether a programme that is technically delivered and operationally adopted also improves patient outcomes, distributes benefits eq...

Open access Research Article 10.9734/jamps/2026/v28i9885

Explainable Artificial Intelligence, Clinician Trust and Diagnostic Accuracy in Multi-modal Medical Imaging: A Critical Narrative Review

Ogechi Okoroafor, Musa Shamaki Ibrahim, Chimuanya Ibecheozor, Chioma Emmanuela Ukatu & Emmanuel Arhin · Journal of Advances in Medical and Pharmaceutical Sciences · 2026

Explainable artificial intelligence is widely promoted as the mechanism through which opaque deep learning systems will earn the confidence of clinicians and improve diagnostic performance in medical imaging. The claim has acquired regulatory and commercial momentum faster than i...

Open access Research Article 10.9734/jamps/2026/v28i8884

Clinical Response and Safety of Letrozole-based Therapy in Postmenopausal Sudanese Women with Estrogen Receptor-positive/HER2-Negative Breast Cancer: A Retrospective Cohort Study

Lina Hassan Elobied, Abdulbagi Elbadri Ali, Mohamed Thabit Ahmed, Kannan O. Ahmed, Yasir S. Kheir, Elmoiz Babekir & Bashir A. Yousef · Journal of Advances in Medical and Pharmaceutical Sciences · 2026

Introduction: Estrogen receptor-positive/HER2-negative breast cancer is the most common molecular subtype of breast cancer. Aromatase inhibitors such as letrozole are part of the standard endocrine treatment regimen for postmenopausal patients; however, real-world evidence on pat...

Open access Research Article 10.9734/jamps/2026/v28i8883